RENOCEL 2000 IU INJECTION

Renocel 2000IU injection is a combination of active ingredients like Recombinant human erythropoietin Alfa/Ep. It is a medication that belongs to a class of drugs called erythropoiesis-stimulating agents (ESAs). This medication helps treat anemia due to chronic kidney diseases (CKD) or chemotherapy for cancer or HIV treatment using zidovudine. It also reduces the requirement for transfusions of red blood cells for those at high risk of losing blood as a result of surgery planned and other treatments.
Renocel 2000IU injection shouldn’t be administered to patients suffering from excessive hypertension, or one of the components thereof active thrombotic microangiopathy (TMA) and purified red cell aplasia (PRCA) seizures that are uncontrolled and pregnancy or lactation. Also, it should be used cautiously in patients who have the background of bleeding clots or heart disease, kidney disease, stroke, liver disease, thalassemia sickle cell anemia(SCA), myelodysplastic disorder, cancer, or leukemia. It should not be used for children younger than 18 years old in cases where the benefits are greater than the risk. Adults who are older and who are taking this medication must be monitored closely for any side negative effects. Before beginning this medication, it’s essential to speak with your physician about the potential risks and advantages associated with Renocel the 2000IU injection dose.